Counseling to improve PrEP access for HIV prevention
Part of Infections clinical trials.
This study tests a counseling program to help more people who could benefit from PrEP (a pill that prevents HIV) actually start taking it. If you're a healthcare provider or someone looking for HIV prevention, this study might help improve access to PrEP.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a healthcare provider (nurse, nurse practitioner, counselor, or physician) with a valid Ontario license, or you are a patient seeking care at one of these clinics.
- For providers: you expect to see at least 5 patients who could benefit from PrEP in the next 3 months.
- For patients: you are 19 or older and identify as a gender other than cisgender woman.
- For patients: you have not taken PrEP in the last 3 months and you have a clinical need for PrEP, such as having had anal sex without a condom with a man plus other risk factors.
- For patients: you can communicate in English and you haven't already declined to join this study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a counseling program to help women decide whether to use PrEP (a daily pill that prevents HIV). It aims to make PrEP choices easier and more informed in sexual and reproductive health clinics.
This trial tests a program where HIV testing counselors help family planning patients learn about and get PrEP, a daily pill that prevents HIV. It aims to make PrEP easier to access in clinics you may already visit.
This study looks at ways to improve PrEP (pre-exposure prophylaxis) care by helping clinic staff track and support patients better. It's for healthcare workers, managers, and data staff at certain PrEP clinics.
This study is for cis-gender men who are HIV-negative and at risk for HIV. It tests a program to help you start and stay on PrEP (medication to prevent HIV).
This study tests a program to help men who have sex with men start and stick with PrEP, a daily pill that prevents HIV. It aims to make PrEP easier to use and reduce HIV risk.
This study tests a program to help men who use stimulants and are at risk for HIV reduce drug use and prevent HIV infection. Participants may get access to PrEP, a daily pill that prevents HIV, and support to lower their risk.
Hear when a new Pre-Exposure Prophylaxis (PrEP) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.